期刊文献+

脂多糖诱导慢性心力衰竭小鼠急性心功能恶化机制

Chronic Heart Failure Induced by Infection of Acute Deter Ioration of Cardiac Function
下载PDF
导出
摘要 目的探讨脂多糖诱导慢性心力衰竭(CHF)小鼠急性心功能恶化的机制。方法 50只KM小鼠,随机分为4组,N组、NS组、HF组、HFS组,N、NS组各10只;HF、HFS组各15只。①HF、HFS组:多柔比星尾静脉注射,每次5 mg/kg,每周1次,共6周,累积总剂量30 mg/kg建立CHF模型。②NS、HFS组:第8周行尾静脉注射脂多糖致CHF急性心功能恶化。16 h后测心脏重量指数,HE染色、免疫组化测定心肌中Bax、Bcl-2、IL-6等表达水平。结果 HF组、HFS组与N、NS组比较,心脏重量指数明显增加(P<0.05);HF组心肌细胞IL-6表达最高,HFS组显著减少(P<0.05),NS组较N组明显升高;HF组Bcl-2较NS组明显升高(P<0.05);HFS组Bax较HF组明显增加(P<0.05)。结论感染致心力衰竭小鼠血浆中的IL-6过表达,同时负反馈使心肌细胞内IL-6减少致心肌细胞促凋亡基因增加。 Objective To investigate the mechanism of acute deterioration of cardiac function when chronic heart failure(CHF) induced by lipopolysaccharide. Methods 50 male KM mices were randomized 4 groups ( normal group and normal stress group, n = 10 in each group; heart failure group and Heart failure stress group, n = 15 in each group)① HF and HFS group:caudal vein injection with doxorubicin 5 mg/kg in everyweek, total time 6 weeks. ② NS and HFS group : After 8 weeks, to lead to acute deterioration of cardiac function by caudal vein injection with lipopolysaccharide. After 16 hours we measured HWI and Bcl-2 and Bax protein expressions by hematoxylin and eosin stain and immunohistochemisty. Results Comparing HF group and HFS group to N group and NS group, HWI significantly increased( P 〈 O. 05 ) ; Cardiac muscle cell IL-6 of HF group expression was the highest, HFS group significantly reduced ( P 〈 0.05 ), NS group were significantly higher than N group; Bcl-2 protein of HF group were significantly higher than NS group(P 〈0.05) ;Bax protein of HFS were significantly higher than that in HF group ( P 〈 0.05 ). Conclusion The mices with chronic heart failure induced by infection lead to IL-6 protein of blood plasma overexpression, and mean- while negative feedback reduce IL-6 of cardiac muscle cell, which lead to increasing crowded apoptosis genes of cardiac muscle cell.
出处 《医学综述》 2011年第1期143-146,共4页 Medical Recapitulate
基金 国家自然科学基金(30872539)
关键词 慢性心力衰竭 脂多糖 急性恶化 白细胞介素6 细胞凋亡 Chronic cardiac failure Lipopolysaccharide Acute exacerbation Interleukin- 6 Apoptosis
  • 相关文献

参考文献12

  • 1Levine B, Kalman J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure[ J]. N Engl J Med, 1990,323 (4) :236-241.
  • 2Gullestad L, Aass H, Field JG, et al. Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure [ J ]. Circulation, 2001,103 ( 2 ) : 220 -225.
  • 3陈白玉,李熙芹,陈晓利.肿瘤坏死因子-α、白细胞介素-1β、-6水平与充血性心力衰竭关系的临床研究[J].临床内科杂志,2006,23(3):184-185. 被引量:19
  • 4Haugen E, Gan LM, Isic A, et al. Increased interleukin-6 but not tumour necrosis factor-alpha predicts mortality in the population of elderly heart failure patients[ J]. Exp Clin Cardiol,2008,13 ( 1 ) :19-24.
  • 5Jacoby JJ, Kalinowski A, Liu MG, et al. Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age [ J]. Proc Natl Acad Sci USA,2003,100 (22) : 12929-12934.
  • 6Lutticken G, Wegenk UM, Yuan J, et al. Association of transcription factor APRF and protein kinase JAK 1 with IL-6 signal transducer gp130[ J]. Science,1994,263(5143) :89-92.
  • 7Stahl N, Boulton TG, Farraggella T, et al. Association and activation of JAK-Tyk kinase by CNTF, L IF, OSM, IL-6 D-receptor components [ J ]. Science, 1994,263 (5143 ) :92-95.
  • 8Saito H, Patterson C, Hu Z, et al. Expression and self-regulatory function of cardiac interleukin-6 during endotoxemia [ J ]. Am J Phvsiol Heart Circ Phvsiol,2000,279 (5) : H2241-H2248.
  • 9陈茂,范忠才,饶莉,邓珏琳,杨庆,黄德嘉.心脏重量指数评价左心功能不全价值的研究[J].四川医学,2005,26(5):483-484. 被引量:15
  • 10Krger S, Kunz D, Graf J, et al. Endotoxin hypersensitivity in chronic heart failure [ J ]. Int J Cardiol,2007,115 (2) : 159-163.

二级参考文献18

  • 1姚恒臣,冯桂芹,张颖新,孔祥泉,王英丽,高航.充血性心力衰竭患者IL-1β的变化及利多卡因对其影响的研究[J].中国急救医学,2001,21(1):12-13. 被引量:2
  • 2Isic A,Scharin TM, Haugen E, et al. TNF alpha-antagonist neither improve cardiac remodelling or cardiac function at early stage of heart failure in diabetic rats[J]. Autoimmunity ,2008 ,41 (6) :473 -477.
  • 3Lainscak M, Anker SD. Prognostic factors in chronic heart failure. A review of serum biomarkers, metabolic changes, symptoms, and scoring systems[ J]. Herz,2009,34(2) : 141 - 147,.
  • 4MacGowan GA, Mann DL, Kormos RL, et al. Circulating interleukin-6 in severe heart failure [ J ]. Am J Cardiol, 1997,79 : 1128 - 1131.
  • 5Suzuki H, Sato R, Sato T, et al. Time-course of changes in the levels of interleukin 6 in acutely decompensated heart failure[ J]. Int J Cardiol, 2005,100:415 -420.
  • 6Tsutamoto T, Hisanaga T,Wada A, et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukln -6 is an important prognostic predictor in patients with congestive heart failure[ J]. J Am Coil Cardiol, 1998,31:391 -398.
  • 7Torre-Amione G, Kapadia S, Lee J, et al. Tumor necrosis factor - and tumor necrosis factor receptors in the failing human heart[ J]. Circulation, 1996,93:704 - 711.
  • 8Arnolda L,McGrath B,Cocks M,et al.Adriamycin cardiomyopathy in the rabbit:an animal model of low output cardiac failure with activation of vasoconstrictor mechanisms [J].Cardiovasc Res,1985,19:378~382.
  • 9Blum A, Miller H. Role of cytokines in heart failure. Am Heart J, 1998,135:181-186.
  • 10Werdan K. Cytokines and heat disease. Attempt at an update. Med Clin,1997,92:432-438.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部